Holtzman, 2004 - Google Patents
In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathologyHoltzman, 2004
- Document ID
- 18251630262501400379
- Author
- Holtzman D
- Publication year
- Publication venue
- Journal of Molecular Neuroscience
External Links
Snippet
The ε4 allele of apolipoprotein E APOE is a risk factor for Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA), and the ε2 allele is associated with a decreased risk for AD. There is strong evidence to suggest that a major, if not the main, mechanism underlying …
- 108090000197 Clusterin 0 title abstract description 45
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Holtzman | In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology | |
| Hardy et al. | Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau | |
| Saunders | Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses | |
| Holtzman et al. | Alzheimer’s disease: the challenge of the second century | |
| Raber et al. | ApoE genotype accounts for the vast majority of AD risk and AD pathology | |
| Verghese et al. | Apolipoprotein E in Alzheimer's disease and other neurological disorders | |
| Holtzman | Role of apoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathy | |
| Irvine et al. | Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases | |
| Yamada | Cerebral amyloid angiopathy: an overview | |
| Bales et al. | Apolipoprotein E, amyloid, and Alzheimer disease | |
| Ringman et al. | Genetic heterogeneity in Alzheimer disease and implications for treatment strategies | |
| Walsh et al. | Deciphering the molecular basis of memory failure in Alzheimer's disease | |
| Huang | Apolipoprotein E and Alzheimer disease | |
| Martins et al. | Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease | |
| Puglielli et al. | Alzheimer's disease: the cholesterol connection | |
| Buttini et al. | Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation | |
| Rosenberg | The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture | |
| Kaur et al. | Cystatin C in Alzheimer's disease | |
| M Niedowicz et al. | Alzheimer's disease: pathological mechanisms and recent insights | |
| Rebeck et al. | Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3 | |
| Tang et al. | Genetic studies in Alzheimer's disease | |
| Akram et al. | Association of ApoE and LRP mRNA levels with dementia and AD neuropathology | |
| Berry et al. | Pathological glial tau accumulations in neurodegenerative disease: review and case report | |
| Han | The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer’s disease | |
| Lee et al. | Perspectives on the amyloid-β cascade hypothesis |